Form 4: Equillium Inc. Director Mark Pruzanski Acquires 20,000 Stock Options
SEC Form 4 Filing
Director Mark Pruzanski acquired 20,000 stock options in Equillium, Inc. on May 22, 2024.
Summary
- Mark Pruzanski, a director of Equillium, Inc., acquired 20,000 stock options on May 22, 2024.
- The options have an exercise price of $1.43.
- The options vest in twelve equal monthly installments starting on May 22, 2024, and will be fully vested by the date of the Issuer's annual meeting of stockholders following the grant date.
- The options expire on May 22, 2034.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating a standard stock option grant. While insider ownership can be a positive signal, this specific event is more procedural.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.
Industry Context
This is a standard Form 4 filing, reflecting a change in beneficial ownership by a company insider. Option grants are a common form of executive compensation in the biotechnology industry.
Key Dates
| Date | Description |
|---|---|
| 05/22/2024 | Date of transaction: Mark Pruzanski acquired 20,000 stock options. |
| 05/23/2024 | Date of filing: Form 4 filing date. |
| 05/22/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.